Aortic Valve Thrombosis in Antiphospholipid Syndrome Causing Coronary Artery Embolic Disease

Main Article Content

Jeremy R Burt*
Kimberly M Beavers
Vincent E Grekoski

Abstract

Antiphospholipid syndrome (APS) is a disorder characterized by the presence of antiphospholipid antibodies which are known to promote thrombus formation and heart valve complications. In this case, a 20 year old African American male presenting with chest pain was found to have APS as well as Budd-Chiari Syndrome. He was then evaluated through the use of cardiac magnetic resonance imaging and cardiac catheterization, which revealed an aortic valve thrombus as well as myocardial infarction from coronary artery emboli. This is the first time this condition has been documented in the literature and serves as an example of successful detection and treatment. The patient underwent coronary artery bypass grafting and the thrombus was surgically removed. The patient was discharged with lifelong prescription for anticoagulant medication.

Downloads

Download data is not yet available.

Article Details

Burt, J. R., Beavers, K. M., & Grekoski, V. E. (2016). Aortic Valve Thrombosis in Antiphospholipid Syndrome Causing Coronary Artery Embolic Disease. Journal of Cardiovascular Medicine and Cardiology, 3(2), 032–034. https://doi.org/10.17352/2455-2976.000028
Case Report(s)

Copyright (c) 2016 Burt JR, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306 .

Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346: 752-763 .

Petri M (2000) Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 15: 145-151 .

Long BR, Leya F (2008) The role of antiphospholipid syndrome in cardiovascular disease. Hematol Oncol Clin North Am 22: 79-94 .

Bulckaen HG, Puisieux FL, Bulckaen ED, Di Pompeo C, Bouillanne OM, et al. (2003) Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease. Mayo Clin Proc 78: 294-298 .

Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, et al. (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum46: 1019-1027 .

Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, et al. (2015) Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism. Circulation 132: 241-250 .